Top

Published in:

01-02-2023 | Levothyroxine | Media release

Safety concern for levothyroxine-containing products: biotin interference with thyroid immunoassays

Published in: Reactions Weekly | Issue 1/2023

Excerpt

A safety notice for levothyroxine-containing products and the risk of biotin interference with thyroid immunoassays has been issued by the Health Products Regulatory Authority (HPRA) in Ireland in a direct healthcare professional communication (DHPC). …

Levothyroxine containing products - Important Safety Information from Amdipharm Limited Ireland and Teva Pharmaceuticals Ireland as approved by the HPRA (20.01.23). Internet Document : 20 Jan 2023. Available from: URL: https://www.hpra.ie/homepage/medicines/safety-notices/item?t=/levothyroxine-containing-products---important-safety-information-from-amdipharm-limited-ireland-and-teva-pharmaceuticals-ireland-as-approved-by-the-hpra-(20.01.23)&id=adb21326-9782-6eee-9b55-ff00008c97d0

Title: Safety concern for levothyroxine-containing products: biotin interference with thyroid immunoassays
Publication date: 01-02-2023
Publisher: Springer International Publishing
Keyword: Levothyroxine
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-32892-8

2024 ASCO Annual Meeting

Springer Medicine

Safety concern for levothyroxine-containing products: biotin interference with thyroid immunoassays

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Diclofenac

Citalopram withdrawal

Lithium/olanzapine

Antiretrovirals

Multiple drugs

Aspirin/clopidogrel